文献速递帕金森病与运动障碍

高密度脂蛋白胆固醇变异性与帕金森病发病风险的相关性

Association of High-Density Lipoprotein Cholesterol Variability and the Risk of Developing Parkinson Disease.
PubMed 文献 · Neurology · 2021-02-03

该研究基于韩国全国人群队列,纳入382,391名65岁以上接受至少3次健康检查者,随访至2017年。结果显示基线HDL-C最低四分位组及HDL-C变异性最高四分位组帕金森病发病风险增加,两者并存时风险最高。

要点

  • 基线HDL-C最低四分位组帕金森病风险较最高组增加20%。
  • HDL-C变异性(VIM)最高四分位组帕金森病风险较最低组增加19%。
  • 基线HDL-C最低且变异性最高者帕金森病风险最高(aHR 1.6)。

核心结论

  • 较低的HDL-C水平及较大的HDL-C变异性与帕金森病发病率升高相关。

研究设计与样本

  • 全国性、基于人群的队列研究,纳入382,391名≥65岁接受至少3次健康检查者,随访至2017年。

主要发现

  • 中位随访5年期间,380,404名参与者中新诊断帕金森病2,733例。
  • 基线HDL-C最低四分位组较最高四分位组帕金森病发病风险增加(aHR 1.20;95%CI 1.08-1.34)。
  • 平均HDL-C最低四分位组较最高四分位组风险增加(aHR 1.16;95%CI 1.04-1.30)。
  • HDL-C变异性(VIM)最高四分位组较最低四分位组风险增加(aHR 1.19;95%CI 1.06-1.33)。
  • 基线HDL-C最低四分位且HDL-C变异性最高四分位组风险最高(aHR 1.6;95%CI 1.31-1.96)。

关键数值与推荐

  • 基线HDL-C最低四分位组aHR 1.20(95%CI 1.08-1.34)。
  • 平均HDL-C最低四分位组aHR 1.16(95%CI 1.04-1.30)。
  • HDL-C变异性(VIM)最高四分位组aHR 1.19(95%CI 1.06-1.33)。
  • 基线HDL-C最低且变异性最高组aHR 1.6(95%CI 1.31-1.96)。

临床怎么用

  • 在老年人群中监测HDL-C水平及其变异性可能有助于识别帕金森病高风险个体。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the longitudinal association among high-density lipoprotein cholesterol (HDL-C) level, HDL-C variability, and the risk of developing Parkinson disease (PD). METHODS: We conducted a nationwide, population-based cohort study. We included 382,391 patients aged ≥65 years who underwent at least 3 health examinations provided by the Korean National Health Insurance System from 2008 to 2013 and followed up until 2017. Individuals with a history of PD and missing values were excluded (n = 1,987). We assessed HDL-C variability using 3 indices, including variability independent of the mean (VIM). A multivariate-adjusted Cox proportional hazards regression analysis was performed. RESULTS: Among the 380,404 participants, 2,733 individuals were newly diagnosed with PD during a median follow-up period of 5 years. The lowest quartile (Q1) group of baseline HDL-C and mean HDL-C was associated with increased PD incidence as compared with the highest quartile (Q4) group (adjusted hazard ratio [aHR], 1.20; 95% confidence interval [CI], 1.08-1.34; and aHR, 1.16; 95% CI, 1.04-1.30, respectively). The Q4 group of HDL-C variability (VIM) was associated with increased PD incidence compared to the Q1 group (aHR, 1.19; 95% CI, 1.06-1.33). The group with the Q1 of baseline HDL-C and with the Q4 of HDL-C variability had the highest risk of PD incidence (aHR, 1.6; 95% CI, 1.31-1.96). CONCLUSION: Lower HDL-C level and greater HDL-C variability were associated with a higher incidence of PD.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Park JH, Lee CW, Nam MJ, et al. Association of High-Density Lipoprotein Cholesterol Variability and the Risk of Developing Parkinson Disease. Neurology. 2021. PMID: 33536275. doi:10.1212/WNL.0000000000011553

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。